SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,991.62 391.71
( 0.49%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

43,604.51 -547.48
(-1.24%)

Dow Jones

6,258.79 -101.60
(1.60%)

Hang Seng

40,307.27 -492.33
(-1.21%)

Nikkei 225

9,068.58 -64.23
(-0.70%)

Forex

USD-INR

87.57 0.14
(0.16%)

EUR-INR

100.09 -0.48
(-0.48%)

GBP-INR

115.87 -0.55
(-0.47%)

JPY-INR

0.58 0.00
(-0.74%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5304659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

172.19

38.43

EPS(TTM)

Face Value()

Div & Yield %

0.16

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	991.31	950.30	920.86	758.14	781.41	876.84
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	991.31	950.30	920.86	758.14	781.41	876.84
Other Income	183.92	334.04	159.68	164.24	44.80	97.13
Stock Adjustments	0.02	0.00	-0.17	-0.15	0.00	0.00
Total Income	1175.25	1284.34	1080.37	922.23	826.21	973.97
EXPENDITURE :
Raw Materials	2.13	75.39	102.19	94.53	60.74	63.52
Power & Fuel Cost	3.08	3.54	3.19	2.73	2.68	5.63
Employee Cost	775.50	670.24	543.50	414.99	413.33	470.99
Other Manufacturing Expenses	33.01	28.29	24.97	12.44	6.12	7.35
Selling & Administrative Expenses	86.28	85.81	102.92	85.91	53.39	96.21
Miscellaneous Expenses	14.50	15.25	13.96	5.07	11.04	33.95
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	3.93
Total Expenditure	914.50	878.52	790.73	615.67	547.30	673.72
Operating Profit	260.75	405.82	289.64	306.56	278.91	300.25
Interest	4.69	4.92	6.96	8.78	9.72	10.90
Gross Profit	256.06	400.90	282.68	297.78	269.19	289.35
Depreciation	21.29	21.13	18.51	17.55	18.90	20.60
Profit Before Tax	234.77	379.77	264.17	280.23	250.29	268.75
Tax	23.37	19.84	39.58	41.97	73.89	60.01
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-2.37	1.13	4.22	3.07	-2.63	-2.52
Reported Net Profit	213.77	358.80	220.37	235.19	179.03	211.26
Extraordinary Items	-0.29	-0.12	-0.16	0.00	-0.17	-0.01
Adjusted Net Profit	214.06	358.92	220.53	235.19	179.20	211.27
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-44.17
P & L Balance brought forward	570.93	430.65	442.40	394.24	256.77	383.19
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	122.27	218.52	232.12	187.03	41.56	293.51
P & L Balance carried down	662.43	570.93	430.65	442.40	394.24	256.77
Dividend	0.00	0.00	0.00	0.00	41.56	293.51
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	440.00	1140.00	1575.00	2100.00	1400.00	2025.00
Dividend Per Share(Rs)	4.40	11.40	15.75	21.00	14.00	20.25
Earnings Per Share-Unit Curr	7.70	12.93	15.89	22.64	17.23	20.33
Earnings Per Share(Adj)-Unit Curr	7.70	12.93	7.95	8.49	6.46	7.62
Book Value-Unit Curr	28.94	25.47	39.91	55.03	50.96	35.93
Book Value(Adj)-Unit Curr	28.94	25.47	19.96	20.64	19.11	13.47

24,565.35 -203.00 (-0.82%)

80,991.62 391.71 ( 0.49%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

43,604.51 -547.48 (-1.24%)

6,258.79 -101.60 (1.60%)

40,307.27 -492.33 (-1.21%)

9,068.58 -64.23 (-0.70%)

87.57 0.14 (0.16%)

100.09 -0.48 (-0.48%)

115.87 -0.55 (-0.47%)

0.58 0.00 (-0.74%)